Short Interest in Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) Expands By 11.8%

Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) was the target of a large increase in short interest in September. As of September 15th, there was short interest totalling 3,083,800 shares, an increase of 11.8% from the August 31st total of 2,757,700 shares. Based on an average daily volume of 2,300 shares, the days-to-cover ratio is currently 1,340.8 days.

Genomma Lab Internacional Price Performance

Shares of OTCMKTS:GNMLF remained flat at $1.13 during trading on Monday. The company has a 50-day moving average of $1.01 and a 200 day moving average of $0.96. Genomma Lab Internacional has a one year low of $0.79 and a one year high of $1.13.

About Genomma Lab Internacional

Genomma Lab Internacional, SAB. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Latin America. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and sexual improvement, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, and infant nutrition.